{"id":62742,"date":"2024-02-19T05:25:23","date_gmt":"2024-02-18T23:55:23","guid":{"rendered":"https:\/\/johnsonfrancis.org\/professional\/?p=62742"},"modified":"2024-02-19T05:35:14","modified_gmt":"2024-02-19T00:05:14","slug":"potential-options-for-reducing-cardiotoxicity-of-anthracyclines","status":"publish","type":"post","link":"https:\/\/johnsonfrancis.org\/professional\/potential-options-for-reducing-cardiotoxicity-of-anthracyclines\/","title":{"rendered":"Potential options for reducing cardiotoxicity of anthracyclines"},"content":{"rendered":"<p><iframe loading=\"lazy\" width=\"560\" height=\"315\" src=\"https:\/\/www.youtube.com\/embed\/fwgyL8XMK7Q?si=2cN-nBkBEBYPN_NP\" title=\"YouTube video player\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" allowfullscreen><\/iframe><br \/>\n<strong><span style=\"color: #0000ff;\">What are the potential options for reducing cardiotoxicity of anthracyclines?<\/span><\/strong><\/p>\n<p>Anthracyclines are an important group of medications useful in the treatment of solid tumours and hematological malignancies. An important limitation is their potential cardiotoxicity which can cause heart failure at varying time intervals, even decades later. Some methods which have been used to prevent cardiotoxicity are longer infusion times, use of liposomal preparations, dexrazoxane, beta blockers and renin-angiotensin system inhibitors, all with different success rates. These strategies have not been universally accepted as useful modalities.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>What are the potential options for reducing cardiotoxicity of anthracyclines? Anthracyclines are an important group of medications useful in the treatment of solid tumours and hematological malignancies. An important limitation is their potential cardiotoxicity which can cause heart failure at varying time intervals, even decades later. Some methods which have been used to prevent cardiotoxicity [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":62748,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","footnotes":""},"categories":[9],"tags":[],"class_list":["post-62742","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Potential options for reducing cardiotoxicity of anthracyclines - All About Cardiovascular System and Disorders<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/johnsonfrancis.org\/professional\/potential-options-for-reducing-cardiotoxicity-of-anthracyclines\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Potential options for reducing cardiotoxicity of anthracyclines - All About Cardiovascular System and Disorders\" \/>\n<meta property=\"og:description\" content=\"What are the potential options for reducing cardiotoxicity of anthracyclines? Anthracyclines are an important group of medications useful in the treatment of solid tumours and hematological malignancies. An important limitation is their potential cardiotoxicity which can cause heart failure at varying time intervals, even decades later. Some methods which have been used to prevent cardiotoxicity [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/johnsonfrancis.org\/professional\/potential-options-for-reducing-cardiotoxicity-of-anthracyclines\/\" \/>\n<meta property=\"og:site_name\" content=\"All About Cardiovascular System and Disorders\" \/>\n<meta property=\"article:published_time\" content=\"2024-02-18T23:55:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-02-19T00:05:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2024\/02\/Potential-options-for-reducing-cardiotoxicity-of-anthracyclines.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"890\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Johnson Francis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Johnson Francis\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/potential-options-for-reducing-cardiotoxicity-of-anthracyclines\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/potential-options-for-reducing-cardiotoxicity-of-anthracyclines\\\/\"},\"author\":{\"name\":\"Johnson Francis\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"headline\":\"Potential options for reducing cardiotoxicity of anthracyclines\",\"datePublished\":\"2024-02-18T23:55:23+00:00\",\"dateModified\":\"2024-02-19T00:05:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/potential-options-for-reducing-cardiotoxicity-of-anthracyclines\\\/\"},\"wordCount\":92,\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/potential-options-for-reducing-cardiotoxicity-of-anthracyclines\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/Potential-options-for-reducing-cardiotoxicity-of-anthracyclines.jpg\",\"articleSection\":[\"General Cardiology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/potential-options-for-reducing-cardiotoxicity-of-anthracyclines\\\/\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/potential-options-for-reducing-cardiotoxicity-of-anthracyclines\\\/\",\"name\":\"Potential options for reducing cardiotoxicity of anthracyclines - All About Cardiovascular System and Disorders\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/potential-options-for-reducing-cardiotoxicity-of-anthracyclines\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/potential-options-for-reducing-cardiotoxicity-of-anthracyclines\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/Potential-options-for-reducing-cardiotoxicity-of-anthracyclines.jpg\",\"datePublished\":\"2024-02-18T23:55:23+00:00\",\"dateModified\":\"2024-02-19T00:05:14+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/potential-options-for-reducing-cardiotoxicity-of-anthracyclines\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/potential-options-for-reducing-cardiotoxicity-of-anthracyclines\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/potential-options-for-reducing-cardiotoxicity-of-anthracyclines\\\/#primaryimage\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/Potential-options-for-reducing-cardiotoxicity-of-anthracyclines.jpg\",\"contentUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/Potential-options-for-reducing-cardiotoxicity-of-anthracyclines.jpg\",\"width\":1200,\"height\":890},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/potential-options-for-reducing-cardiotoxicity-of-anthracyclines\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Potential options for reducing cardiotoxicity of anthracyclines\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\",\"name\":\"All About Cardiovascular System and Disorders\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\",\"name\":\"Johnson Francis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"caption\":\"Johnson Francis\"},\"logo\":{\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\"},\"description\":\"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/author\\\/jf\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Potential options for reducing cardiotoxicity of anthracyclines - All About Cardiovascular System and Disorders","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/johnsonfrancis.org\/professional\/potential-options-for-reducing-cardiotoxicity-of-anthracyclines\/","og_locale":"en_US","og_type":"article","og_title":"Potential options for reducing cardiotoxicity of anthracyclines - All About Cardiovascular System and Disorders","og_description":"What are the potential options for reducing cardiotoxicity of anthracyclines? Anthracyclines are an important group of medications useful in the treatment of solid tumours and hematological malignancies. An important limitation is their potential cardiotoxicity which can cause heart failure at varying time intervals, even decades later. Some methods which have been used to prevent cardiotoxicity [&hellip;]","og_url":"https:\/\/johnsonfrancis.org\/professional\/potential-options-for-reducing-cardiotoxicity-of-anthracyclines\/","og_site_name":"All About Cardiovascular System and Disorders","article_published_time":"2024-02-18T23:55:23+00:00","article_modified_time":"2024-02-19T00:05:14+00:00","og_image":[{"width":1200,"height":890,"url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2024\/02\/Potential-options-for-reducing-cardiotoxicity-of-anthracyclines.jpg","type":"image\/jpeg"}],"author":"Johnson Francis","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Johnson Francis"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/johnsonfrancis.org\/professional\/potential-options-for-reducing-cardiotoxicity-of-anthracyclines\/#article","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/potential-options-for-reducing-cardiotoxicity-of-anthracyclines\/"},"author":{"name":"Johnson Francis","@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"headline":"Potential options for reducing cardiotoxicity of anthracyclines","datePublished":"2024-02-18T23:55:23+00:00","dateModified":"2024-02-19T00:05:14+00:00","mainEntityOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/potential-options-for-reducing-cardiotoxicity-of-anthracyclines\/"},"wordCount":92,"publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/potential-options-for-reducing-cardiotoxicity-of-anthracyclines\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2024\/02\/Potential-options-for-reducing-cardiotoxicity-of-anthracyclines.jpg","articleSection":["General Cardiology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/johnsonfrancis.org\/professional\/potential-options-for-reducing-cardiotoxicity-of-anthracyclines\/","url":"https:\/\/johnsonfrancis.org\/professional\/potential-options-for-reducing-cardiotoxicity-of-anthracyclines\/","name":"Potential options for reducing cardiotoxicity of anthracyclines - All About Cardiovascular System and Disorders","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#website"},"primaryImageOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/potential-options-for-reducing-cardiotoxicity-of-anthracyclines\/#primaryimage"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/potential-options-for-reducing-cardiotoxicity-of-anthracyclines\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2024\/02\/Potential-options-for-reducing-cardiotoxicity-of-anthracyclines.jpg","datePublished":"2024-02-18T23:55:23+00:00","dateModified":"2024-02-19T00:05:14+00:00","breadcrumb":{"@id":"https:\/\/johnsonfrancis.org\/professional\/potential-options-for-reducing-cardiotoxicity-of-anthracyclines\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/johnsonfrancis.org\/professional\/potential-options-for-reducing-cardiotoxicity-of-anthracyclines\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/johnsonfrancis.org\/professional\/potential-options-for-reducing-cardiotoxicity-of-anthracyclines\/#primaryimage","url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2024\/02\/Potential-options-for-reducing-cardiotoxicity-of-anthracyclines.jpg","contentUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2024\/02\/Potential-options-for-reducing-cardiotoxicity-of-anthracyclines.jpg","width":1200,"height":890},{"@type":"BreadcrumbList","@id":"https:\/\/johnsonfrancis.org\/professional\/potential-options-for-reducing-cardiotoxicity-of-anthracyclines\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/johnsonfrancis.org\/professional\/"},{"@type":"ListItem","position":2,"name":"Potential options for reducing cardiotoxicity of anthracyclines"}]},{"@type":"WebSite","@id":"https:\/\/johnsonfrancis.org\/professional\/#website","url":"https:\/\/johnsonfrancis.org\/professional\/","name":"All About Cardiovascular System and Disorders","description":"","publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/johnsonfrancis.org\/professional\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec","name":"Johnson Francis","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","caption":"Johnson Francis"},"logo":{"@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g"},"description":"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal","url":"https:\/\/johnsonfrancis.org\/professional\/author\/jf\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/62742","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/comments?post=62742"}],"version-history":[{"count":5,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/62742\/revisions"}],"predecessor-version":[{"id":62749,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/62742\/revisions\/62749"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media\/62748"}],"wp:attachment":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media?parent=62742"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/categories?post=62742"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/tags?post=62742"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}